Remove 2026 Remove Communication Remove Drug Development
article thumbnail

NHC Comments on IRA Guidance Response

Putting Patients First Blog

10: External Data Submission Timing The NHC understands the tight timeline for the drug selection and price negotiation processes. 60: Input Process for Future Program Guidance The NHC appreciates the opportunity to comment on initial program guidance for IPAY 2026 and seeks clarification on processes for seeking feedback moving forward.

article thumbnail

Cloud Computing for Pharma: The Road to Digital Transformation 

Viseven

When COVID hit, the urgent need to accelerate drug development meant shrinking timelines from years to months, with no room for compromises on quality. This innovative approach has brought more than 40 successful drug discovery projects to AstraZeneca. By the end of 2026, the company will be able to analyze two million genomes.